These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32357212)

  • 1. In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
    Thieme L; Hartung A; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2020 Aug; 75(8):2173-2181. PubMed ID: 32357212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.
    Luther MK; Rice LB; LaPlante KL
    Antimicrob Agents Chemother; 2016 May; 60(5):3178-82. PubMed ID: 26926624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis.
    Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM;
    J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an
    Cusumano JA; Daffinee KE; Piehl EC; García-Solache M; Desbonnet C; Rice LB; LaPlante KL
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0042622. PubMed ID: 36154173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.
    Gavaldà J; Torres C; Tenorio C; López P; Zaragoza M; Capdevila JA; Almirante B; Ruiz F; Borrell N; Gomis X; Pigrau C; Baquero F; Pahissa A
    Antimicrob Agents Chemother; 1999 Mar; 43(3):639-46. PubMed ID: 10049280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
    Werth BJ; Abbott AN
    J Antimicrob Chemother; 2015 Aug; 70(8):2414-7. PubMed ID: 25953804
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D
    J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.
    Euba G; Lora-Tamayo J; Murillo O; Pedrero S; Cabo J; Verdaguer R; Ariza J
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4305-10. PubMed ID: 19667290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of rifampicin combination therapy for the treatment of enterococcal infections assessed in vivo using a Galleria mellonella infection model.
    Skinner K; Sandoe JAT; Rajendran R; Ramage G; Lang S
    Int J Antimicrob Agents; 2017 Apr; 49(4):507-511. PubMed ID: 28235571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates.
    Cusumano JA; Khan R; Shah Z; Philogene C; Harrichand A; Huang V
    Microbiol Spectr; 2022 Aug; 10(4):e0062122. PubMed ID: 35703558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.
    Liao CH; Huang YT; Tsai HY; Hsueh PR
    Int J Antimicrob Agents; 2014 Jul; 44(1):85-6. PubMed ID: 24888868
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.
    Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A
    Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.